Kanamycin-is an antibiotic used to treat severe bacterial infections and tuberculosis.

Kanamycin A, often referred to as simple kanamycin, is an antibiotic used to treat severe bacterial infections and tuberculosis. It is not a first line treatment. It is used by mouth, injection into a vein, or injection into a muscle.

Kanamycin-is an antibiotic used to treat severe bacterial infections and tuberculosis.

Kanamycin, Kanamycin Base, Kanamycinum

Efficin, Kanamac, Kanamycin, Kancin, Neokanyn, Tiniba INF

(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-3-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}oxane-3,4,5-triol

The recommended dose is 500 mg to 1g per day in divided doses as IV/IM route.

Prescribed for serious bacterial infections.

Pain, inflammation, bruising, haematoma at inj site; GI disturbances; malabsorption of fat. Potentially Fatal: Neuromuscular blockade; nephrotoxicity; ototoxicity.

• Synergistic effects with ampicillin, benzylpenicillin and other β-lactam antibiotics.
• May reduce renal excretion of zalcitabine.
• Increased risk of ototoxicity with ethacrynic acid and furosemide.
• Increased risk of nephrotoxicity with cisplatin, cephalosporins, vancomycin, ciclosporin, hydrocortisone and indomethacin.
• Potentiates effects of neuromuscular blocking agents.

Hypersensitivity. GI ulceration

Store at 20-25 ?

Molecular weight

484.4986

Molecular formula

C18H36N4O11

CAS number

59-01-8

Precautions

Renal impairment, dehydration, previous exposure to ototoxic drugs; preexisting tinnitus, vertigo or subclinical hearing loss. Parkinsonism, myasthenia gravis. Infants, neonates, elderly. Pregnancy, lactation. It should not be used on long treatment.